Unimed Pharmaceuticals, LLC
Records under this name other than the patents Unimed Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Unimed Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,466,137 | Testosterone Gel and Method of Use Term ended Ended no later than Oct 12, 2026 · Low confidence | Term ended | Ended no later than Oct 12, 2026 | Low confidence |
| US 8,729,057 | Testosterone gel and method of use Formerly held In force Ended no later than Oct 12, 2026 · From the USPTO record | In force | Ended no later than Oct 12, 2026 | From the USPTO record |
| US 8,741,881 | Testosterone gel and method of use Formerly held In force Ended no later than Oct 12, 2026 · From the USPTO record | In force | Ended no later than Oct 12, 2026 | From the USPTO record |
| US 8,754,070 | Testosterone gel and method of use Formerly held In force Ended no later than Oct 12, 2026 · From the USPTO record | In force | Ended no later than Oct 12, 2026 | From the USPTO record |
| US 8,759,329 | Testosterone gel and method of use Formerly held In force Ended no later than Oct 12, 2026 · From the USPTO record | In force | Ended no later than Oct 12, 2026 | From the USPTO record |
| US 7,648,696 | Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent Formerly held Term ended Term ended Jun 20, 2021 · From the USPTO record | Term ended | Term ended Jun 20, 2021 | From the USPTO record |
| US 6,703,418 | Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection Term ended Term ended Mar 9, 2021 · From the USPTO record | Term ended | Term ended Mar 9, 2021 | From the USPTO record |
| US 6,503,894 | Pharmaceutical composition and method for treating hypogonadism Term ended Term ended Aug 30, 2020 · From the USPTO record | Term ended | Term ended Aug 30, 2020 | From the USPTO record |
| US 9,125,816 | Pharmaceutical composition and method for treating hypogonadism Term ended Ended no later than Aug 30, 2020 · From the USPTO record | Term ended | Ended no later than Aug 30, 2020 | From the USPTO record |
| US 9,132,089 | Pharmaceutical composition and method for treating hypogonadism Term ended Ended no later than Aug 30, 2020 · From the USPTO record | Term ended | Ended no later than Aug 30, 2020 | From the USPTO record |